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Purpose: In epidemiologic and animal studies, a high fat diet (HFD) has been 
shown to be associated with lower bone mineral density (BMD) and a higher risk 
of osteoporotic fractures. Meanwhile, consuming a HFD containing diacylglycerol 
(DAG) instead of triacylglycerol (TAG) is known to offer metabolically beneficial 
effects of reductions in body weight and abdominal fat. The purpose of this study 
was to investigate the effects of a HFD containing DAG (HFD-DAG) on bone in 
mice. Materials and Methods: Four-week-old male C57BL/6J mice (n=39) were 
divided into three weight-matched groups based on diet type: a chow diet group, a 
HFD containing TAG (HFD-TAG) group, and a HFD-DAG group. After 20 weeks, 
body composition and bone microstructure were analyzed using dual energy X-ray 
absorptiometry and micro-computed tomography. Reverse transcription-poly-
merase chain reaction (PCR) and real-time PCR of bone marrow cells were per-
formed to investigate the expressions of transcription factors for osteogenesis or ad-
ipogenesis. Results: The HFD-DAG group exhibited lower body weight, higher 
BMD, and superior microstructural bone parameters, compared to the HFD-TAG 
group. The HFD-DAG group showed increased expression of Runx2 and de-
creased expression of PPARγ in bone marrow cells, compared to the HFD-TAG 
group. The HFD-DAG group also had lower levels of plasma glucose, insulin, total 
cholesterol, and triglyceride than the HFD-TAG group. Conclusion: Compared to 
HFD-TAG, HFD-DAG showed beneficial effects on bone and bone metabolism in 
C57BL/6J mice.
Key Words:   High fat diet, bone mineral density, osteoporotic fractures, diacylg-
lycerol, triacylglycerol, bone metabolism
INTRODUCTION
High levels of dietary fat are metabolically harmful to one’s health. Several cardio-
metabolic disorders, such as obesity, hyperlipidemia, diabetes mellitus, and cardio-
vascular disease, have been shown to be associated with high fat diets (HFDs).1 Re-
cently, epidemiologic studies have shown that a HFD is also associated with lower 
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study, the mice were housed in standard cages placed in a 
room at 21±2°C and 50±5% relative humidity, with a 12-
hour light-dark cycle. The animals used in this study were 
treated in accordance with the Guide for the Care and Use of 
Laboratory Animals (Institute of Laboratory Animal Re-
sources, Commission on Life Sciences, National Research 
Council, 1996), as approved by the Institutional Animal Care 
and Use Committee of Yonsei University.
Experimental protocol
Mice were fed a standard laboratory diet for one week in or-
der to acclimatize them. They were then divided into three 
weight-matched groups (n=13 per group) of three different 
diet types: the chow diet group, the HFD-TAG group, and 
the HFD-DAG group. The chow diet consisted of a purified 
diet based on the AIN-93G rodent diet, which contains 7 
gm% (16 kcal%) of fat;26 the chow diet in the present study 
comprised 4.0 kcal per gm of fat. Both the HFD-TAG and 
HFD-DAG contained 24 gm% (45 kcal%) of fat. Although 
the amount of fat in the HFD-DAG was identical to that in 
the HFD-TAG, the fat content was different. Seventy grams 
of soybean oil and 130 g of lard were used for the HFD-
TAG, while 150 g of DAG oil and 50 g of lard were used 
for the same total amount of fat in the HFD-DAG. Both di-
ets comprised 4.8 kcal per gm of fat. Detailed ingredients of 
each diet are listed in Table 1. All mice were allowed free 
access to food and water throughout the 20-week test peri-
od. The mice were weighed every week from the beginning 
of the study. Every four weeks, mice were anesthetized us-
ing a mixture of Zoletil and Rompun, and body composition 
was measured. At the end of the experimental period, mice 
were sacrificed following 12-h fasts. Blood was drawn by 
cardiac puncture from mice into EDTA-coated tubes. Plas-
ma was obtained by centrifuging the blood at 2000× g for 
15 min at 4°C. The plasma was then frozen and stored at 
-20°C until ready for analysis. Femora and tibiae from the 
hind legs were dissected and bone marrow cells were imme-
diately isolated from the tibiae. The Yonsei University Insti-
tutional Animal Care and Use Committee approved all ani-
mal experiment protocols.
Body composition and bone microstructure
Body composition (lean mass, fat mass, bone mineral con-
tent, and BMD) of the mice was measured using dual X-ray 
absorptiometry (DXA) (QDR-4500A, Hologic, Waltham, 
MA, USA). The instrument was calibrated before scanning 
sessions using a phantom with known BMD, according to 
bone mineral density (BMD) and higher risk of osteoporot-
ic fractures.2,3 Animal studies have demonstrated that HFDs 
also exert adverse effects on bone metabolism.4-7 Although 
the mechanisms for these effects are unclear, metabolic de-
rangements, such as dyslipidemia or oxidative stress, result-
ing from excess fat intake, may mediate the harmful effects 
of dietary fat on bone.8-12
The majority of dietary fat consists of triacylglycerol 
(TAG), a glyceride composed of three fatty acid chains cova-
lently bonded to a glycerol molecule through ester linkages. 
Diacylglycerol (DAG) is a glyceride that comprises two fatty 
acid chains esterified to a glycerol molecule. DAG oil is sim-
ilar in taste, appearance, and fatty acid composition to con-
ventional edible oils that predominantly consist of TAG. In 
fact, various edible oils contain small quantities of DAG, 
ranging from 0.8% in rapeseed oil to 9.5% in cottonseed 
oil.13 DAG exists in two isoforms, 1,2 (or 2,3)-DAG and 1,3-
DAG. Typically, DAG in edible oils exists as the 1,3-isoform 
DAG due to migration of the acyl group in an equilibrium re-
action. This 1,3-DAG is believed to offer metabolically ben-
eficial effects, compared to TAG, due to differences in ab-
sorption and metabolism.14,15 As demonstrated in both animal 
and human studies, DAG appears to be more effective than 
TAG in preventing hyperlipidemia and excess body fat accu-
mulation.16-25 Regarding the safety of DAG, most studies that 
have investigated the dietary toxicity of DAG report no se-
vere adverse effects related to its consumption.14
While previous animal studies have demonstrated the ef-
fects of HFDs on bone and bone metabolism,4-7 no studies 
have investigated the effects of a HFD containing DAG 
(HFD-DAG) on bone. We hypothesized that a HFD-DAG 
may affect bone and its metabolism differently than a HFD 
containing TAG (HFD-TAG), owing to the beneficial ef-
fects of DAG on fat mass, lipid metabolism, and/or oxida-
tive stress. To test this hypothesis, we measured body com-
position, bone microstructure, and biochemical parameters 
in mice fed three different diets, including a chow diet, a 
HFD-TAG, and a HFD-DAG, for 20 weeks. Gene expres-
sion for osteogenic or adipogenic differentiation of bone 
marrow cells was also investigated.
MATERIALS AND METHODS
Animals
Four-week-old male C57BL/6J mice were purchased from 
Central Laboratory Animal Inc. (Seoul, Korea). During the 
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PCR) analysis, one microliter of the RT product was used 
as a template for PCR amplification of Runx2, osterix, 
PPARγ, and β-actin using the following cycles: Runx2, 
94°C for 40 s, 55°C for 40 s, and 72°C for 1 min over 28 cy-
cles; osterix, 94°C for 40 s, 55°C for 40 s, and 72°C for 1 
min over 30 cycles; PPARγ, 94°C for 40 s, 58°C for 40 s, 
and 72°C for 1 min over 30 cycles; β-actin, 94°C for 40 s, 
55°C for 40 s, and 72°C for 1 min over 20 cycles. The mea-
sured mRNA levels were normalized to the β-actin mRNA 
levels. Sequence information on the oligonucleotide primers 
used for RT-PCR is presented in Table 2. PCR products 
were separated by electrophoresis on a 1.5% agarose gel and 
visualized by ethidium bromide staining. Real-time RT-PCR 
quantitation of Runx2 and PPARγ mRNA was performed in 
an iCycler IQ detection system (Bio-Rad, Hercules, CA, 
USA) using SYBR Green I (Molecular Probes, Eugene, 
OR, USA) as a double-strand DNA-specific binding dye. 
The sequence information of oligonucleotide primers for 
quantitative real time RT-PCR is also presented in Table 2. 
Biochemical analyses
Plasma concentrations of glucose, total cholesterol, triglyc-
eride, and high density lipoprotein (HDL)-cholesterol were 
measured using an ADVIA 1650 Chemistry system (Sie-
mens, Tarrytown, NY, USA). Plasma insulin levels were 
measured with an enzyme-linked immunosorbent assay kit 
(Mercodia, Uppsala, Sweden), and the inter-assay and intra-
assay variations were 4.8±1.3% and 2.6±0.6%, respectively. 
The homeostatic model assessment of insulin resistance 
the manufacturer’s guidelines. Body composition excluding 
the skull was assessed every four weeks from the fourth 
week of experimental period. All scans were performed 
with the animals positioned prone and spread, with tape at-
tached to each limb on the platform. The lean or fat mass 
percentage was calculated as lean or fat mass divided by to-
tal body weight. At the end of the study, the microarchitec-
tures of the femora and the fifth lumbar vertebrae from sac-
rificed mice were analyzed using micro-computed tomo-
graphy (micro-CT) scanning (SMX-90CT, Shimadzu, Kyoto, 
Japan). The cortical bone and trabecular bone were separat-
ed manually on each slice by a cursor line. The three-dimen-
sional structure was analyzed using the TRI 3D-BON (RAC-
TOC System Engineering Co., Tokyo, Japan) program. In 
this study, the morphometric parameters calculated for both 
skeletal sites included bone volume fraction (BV/TV, %), 
trabecular thickness (μm), trabecular number (1/mm), and 
trabecular separation (μm). Femoral images were also eval-
uated for cortical thickness (μm) and cortical cross-sectional 
area (mm2).
Total RNA isolation, RT-PCR, and quantitative real-
time RT-PCR
The total RNA of tibial bone marrow cells (n=5 for each 
group) was extracted using Trizol reagent (Invitrogen, Carls-
bad, CA, USA), and then reverse transcribed into cDNA us-
ing M-MuLV reverse transcriptase (Promega, Madison, WI, 
USA) according to the manufacturer’s recommendations. 
For reverse transcription-polymerase chain reaction (RT-
Table 1. Composition of Experimental Diets
Formula
Chow (AIN-93G) HFD-TAG HFD-DAG
gm kcal gm kcal gm kcal
Casein, lactic 200.0 800 200.0 800 200.0 800
L-cystine 3.0 12 3.0 12 3.0 12
Corn starch 397.486 1590 165.9 664 165.9 664
Sucrose 100.0 400 73.5 294 73.5 294
Dextrose 132.0 528 97.6 390 97.6 390
Cellulose 50.0 0 50.0 0 50.0 0
Soybean oil 70.0 630 70.0 630 0 0
Lard 0 0 130.0 1170 50.0 450
DAG 0 0 0 0 150.0 1350
t-butylhydroquinone 0.014 0 0.014 0 0.014 0
AIN-93 mineral mix 35.0 0 35.0 0 35.0 0
AIN-93 vitamin mix 10.0 40 10.0 40 10.0 40
Choline bitartrate 2.5 0 2.5 0 2.5 0
Total 1000.0 4000 837.514 4000 837.514 4000
HFD-TAG, high fat diet containing triacylglycerol; HFD-DAG, high fat diet containing diacylglycerol.
Han Seok Choi, et al.
Yonsei Med J   http://www.eymj.org   Volume 56   Number 4   July 2015954
HFD-TAG group showed greater body weight (p<0.001), 
lean mass (p=0.008), and fat mass (p<0.001) than the HFD-
DAG group. The difference between the groups increased 
from the beginning of the experimental period. The fat mass 
percentage of the HFD-TAG group was also greater than 
that of the HFD-DAG group (p<0.001). However, the lean 
mass percentage was higher in the HFD-DAG group than in 
the HFD-TAG group (p<0.001). 
BMD and bone microstructure
BMD measured by DXA at each time point is presented in 
Fig. 1D. BMD was higher in mice fed a HFD containing ei-
ther TAG or DAG than in those fed the chow diet, which is 
probably due to the greater body weight of mice fed the 
HFD. Among mice fed a HFD, however, those fed the HFD-
DAG had greater BMD than those fed the HFD-TAG, de-
spite having lower body weight (p=0.016). After statistical 
adjustment for body weight, mice fed the HFD-DAG had 
greater BMD at 20 weeks than those fed the chow diet (p< 
0.001) or HFD-TAG (p=0.017). However, there was no sta-
tistical difference in BMD at 20 weeks between the chow 
diet group and the HFD-TAG group after adjusting for body 
weight (p=0.128). Micro-CT was conducted after sacrificing 
the animals to analyze the microstructures of cortical and tra-
becular bone. The femur of the posterior limb and the fifth 
lumbar vertebra were used for micro-CT analysis. Compared 
to mice fed the HFD-TAG, mice fed the HFD-DAG showed 
increased cortical thickness and cross-sectional area in their 
(HOMA-IR) was calculated from fasting plasma glucose 
and insulin concentrations.
Statistical analyses
Statistical analyses were performed using SPSS 15 (SPSS 
Inc., Chicago, IL, USA). Data are reported as mean±standard 
error. Comparisons across groups were performed by one-
way analysis of variance (ANOVA) with a post hoc Dun-
can’s test. A repeated measures ANOVA was performed to 
test for significant differences in the means of body weight, 
fat mass, lean mass, and BMD over time between groups. 
Multiple comparisons after repeated measures ANOVA 
were carried out using Bonferroni’s method. A doubly mul-
tivariate analysis of variance with a post hoc Turkey’s hon-
estly significant difference test was also performed to com-
pare the mean differences among groups for univariate 
analysis of BMD after adjusting for body weight. All p-val-
ues<0.05 were considered statistically significant. 
RESULTS
Body weight and composition
Body weight, lean mass, and fat mass measured at each time 
point for the three diet groups are shown in Fig. 1A, B, and 
C. The body weights, lean masses, and fat masses of mice 
fed a HFD were greater than those of mice fed the chow diet 
at each time point. Among mice that were fed a HFD, the 
Table 2. Sequences of Primers and PCR Reaction Parameters Used in RT-PCR and Quantitative Real-Time RT-PCR
                    Target gene                             Primer sequence AT (°C) Cycles
RT-PCR
β-actin
(F) 5’-GATAGCGATATCGCTGCGCT-3’
(R) 5’-GCTCATTGCCGATAGTGATGACCT-3’ 
55 20
Runx2
(F) 5’-CCGCACGACAACCGCACCAT-3’
(R) 5’-CGCTCCGGCCCACAAATCTC-3’
55 28
Osterix
(F) 5’-CACATCCCTGGTGCGGCAA-3’
(R) 5’-CCGGGTGTGAGTGCGCACAT-3’
55 30
PPARγ
(F) 5’-CACTTCACAAGAAATTACCAT-3’
(R) 5’-GAAGGACTTTATGTATGAGTC-3’ 
58 30
Quantitative real-time RT-PCR
GAPDH
(F) 5’-AATGTGTCCGTCGTGGATCTG-3’
(R) 5’-CAACCTGGTCCTCAGTGTAGC-3’ 
55 40
Runx2
(F) 5’-CAGATGACATCCCCATCCATCC-3’
(R) 5’-AAGTCAGAGGTGGCAGTGTC-3’ 
55 40
PPARγ
(F) 5’-GCCCTGGCAAAGCATTTGTATG-3’
(R) 5’-CCCATCATTAAGGAATTCATGTCGTAG-3’
58 40
RT-PCR, reverse transcription-polymerase chain reaction; AT, annealing temperature.
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a HFD containing either TAG or DAG had higher fasting 
glucose, HOMA-IR, total cholesterol, and triglyceride than 
mice fed the chow diet. Among mice fed a HFD, however, 
metabolic derangement was more severe in the mice fed the 
HFD-TAG than in those fed the HFD-DAG.
DISCUSSION
The present study revealed that mice fed a HFD-DAG have 
greater BMD and superior bone microstructure, compared 
to those fed a HFD-TAG. The HFD-DAG group also showed 
increased expression of Runx2 and decreased expression of 
PPARγ in bone marrow cells, compared to the HFD-TAG 
group. These findings suggest that the beneficial effects of 
DAG on bone might result from increased differentiation of 
bone marrow cells into an osteogenic rather than adipogenic 
lineage. This study also showed that mice fed a HFD-DAG 
gained less body weight and fat mass than mice fed a HFD-
femoral bones (Figs. 2A and 3) and increased trabecular 
thickness in their vertebrae (Figs. 2B and 4), despite having 
lower body weight.
Differentiation of bone marrow cells
Bone marrow cells were isolated from mice tibiae (n=5) to 
determine the effect of diet on cell differentiation. The gene 
expression levels of transcription factors for osteogenic and 
adipogenic lineage in bone marrow cells are presented in 
Fig. 5. RT-PCR (Fig. 5A) and quantitative real time RT-PCR 
(Fig. 5B) reveal significant up-regulation of Runx2 and os-
terix, transcription factors for osteoblastic differentiation, in 
mice fed the HFD-DAG, compared with those fed the HFD-
TAG. In contrast, the adipocyte-specific transcription factor 
PPARγ was up-regulated in mice fed the HFD-TAG. 
Metabolic parameters
Biochemical parameters, including fasting plasma glucose, 
insulin, and lipid profiles, are presented in Table 3. Mice fed 
Fig. 1. Changes in body weight, lean mass, fat mass, and BMD in mice fed a chow diet (solid line ), HFD-TAG (dashed line ), and HFD-DAG (dotted line 
). Repeated measures ANOVA, p<0.001 for body weight (A), lean mass (B), fat mass (C), and BMD (D). HFD-TAG, high fat diet containing triacylglycerol; 
HFD-DAG, high fat diet containing diacylglycerol; BMD, bone mineral density; ANOVA, analysis of variance. 
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TAG. Furthermore, biochemical tests in this study revealed 
lower levels of plasma glucose, insulin, total cholesterol, and 
triglyceride in the HFD-DAG group than the HFD-TAG 
group, findings which are consistent with previous studies 
on the metabolic effects of DAG.16-25 Based on the results of 
our study, we speculate that the beneficial effects of DAG 
on bone are partly due to less glucotoxicity and lipotoxicity. 
Another interesting finding in our study was that mice fed 
an HFD-DAG also had greater BMD, superior bone micro-
structure, and increased expression of Runx2 in bone mar-
row cells, compared to those fed a chow diet, although the 
HFD-DAG group had higher levels of plasma glucose, insu-
lin, total cholesterol, and triglyceride. This finding suggests 
that metabolic derangements associated with a HFD-DAG 
are not severe enough to exert a negative effect on bone me-
tabolism in mice. On the contrary, greater body weight of 
mice fed a HFD-DAG might have positively affected their 
bone.
Dietary fat intake can affect bone metabolism in several 
ways. Excess body fat accumulation resulting from a HFD 
has both positive and negative effects on bone. The mechan-
ical loading of accumulated fat mass can stimulate osteo-
genesis and estrogen produced in adipose tissue and inhibit 
bone resorption by osteoclasts.27 In contrast, adipocytes may 
exert lipotoxic effects on osteoblasts, as shown in an experi-
Chow
Chow
HFD-TAG
HFD-TAG
HFD-DAG
HFD-DAG
A
B
Fig. 2. Microstructure images of femoral bones (A) and fifth lumbar verte-
brae (B) in mice. HFD-TAG, high fat diet containing triacylglycerol; HFD-
DAG, high fat diet containing diacylglycerol.
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Fig. 3. Microstructure parameters of femoral bones in mice (A-F). (A) BV/TV, (B) Tb.Th, (C) Tb.N, (D) Tb.Sp, (E) CT, (F) CSA. * versus † indicates a statistically 
significant difference. * versus * means no significant difference. BV, bone volume; TV, tissue volume; Tb.Th, trabecular thickness; Tb.N, trabecular number; 
Tb.Sp, trabecular separation; CT, cortical thickness; CSA, cross-sectional area; HFD-TAG, high fat diet containing triacylglycerol; HFD-DAG, high fat diet con-
taining diacylglycerol.
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all effect of adipocytokines on bone remains unclear.
Recently, oxidative stress was suggested as an important 
mediator of HFD-induced bone loss.7 Studies showed that 
excess fat intake increases oxidative stress by overproducing 
reactive oxygen species and decreasing antioxidant enzyme 
activity.35,36 Oxidative stress may be a cause of the develop-
ment of osteoporosis. In previous clinical studies, oxidative 
stress exhibited an inverse association with bone mass in 
humans.11,12,37,38 In vitro and animal studies have also shown 
that oxidative stress can inhibit the differentiation of osteo-
blasts39,40 while stimulating the formation and activation of 
ment where adipocytes induced the inhibition of osteoblast 
proliferation in in vitro cocultures.28 Adipocytokines secret-
ed by adipose tissue can also affect bone metabolism in both 
positive and negative ways. For example, leptin inhibits 
bone formation through a central mechanism that involves 
the sympathetic nervous system.29,30 However, peripheral 
administration of leptin increases cortical bone growth and 
differentiation of mesenchymal stem cells into osteoblasts 
rather than adipocytes,31,32 and reduces ovariectomy-induced 
bone loss in rats.33 Adiponectin also seems to have both pos-
itive and negative impacts on bone metabolism.34 The over-
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Table 3. Comparison of Metabolic Parameters Measured in the Plasma of Mice
Chow diet HFD-TAG HFD-DAG p value
Glucose (mg/dL)   81.5±2.0* 169.7±4.7‡ 106.2±4.3† <0.001
Insulin (ng/mL)     0.6±0.1*      1.4±0.2†      0.9±0.1* <0.001
HOMA-IR     2.8±0.5*   13.8±2.0†      5.4±0.6* <0.001
Triglyceride (mg/dL)   77.3±2.5* 102.2±4.0‡   91.1±2.7† <0.001
Total cholesterol (mg/dL) 113.5±4.3* 168.9±5.3‡ 130.0±6.3† <0.001
HDL-cholesterol (mg/dL) 67.6±2.5   61.9±1.7  65.3±1.7 0.149
HFD-TAG, high fat diet containing triacylglycerol; HFD-DAG, high fat diet containing diacylglycerol; HOMA-IR, homeostatic model assessment of insulin re-
sistance; HDL, high density lipoprotein.
Means with different superscript letters within a row are significantly different (p<0.05) (* versus † or * versus ‡ or † versus ‡ indicates a statistically signifi-
cant difference, * versus * means no significant difference).
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phometry was not conducted. Although bone formation and 
resorption markers were measured in the plasma, how a 
HFD-DAG affects bone remodeling differently than a HFD-
TAG or chow diet is unclear. Dynamic histomorphometry 
study might have provided a more definitive explanation. 
Second, plasma concentrations of adipocytokines, such as 
leptin and adiponectin, were not measured, and these adipo-
cytokines might play a role in mediating metabolism of a 
HFD and bone. In addition, mice used in the present study 
were 4 weeks of age, corresponding to pre-pubertal stage of 
development. Therefore, we must be careful about extrapo-
lating the current findings to humans.
In conclusion, we demonstrated that DAG exerts positive 
effects on bone metabolism in mice. Accordingly, consum-
ing a diet rich in DAG instead of TAG may be beneficial to 
preventing bone loss and managing osteoporosis. Further re-
search is needed to elucidate the mechanisms behind the 
beneficial effects of DAG on bone. 
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